NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12/25/2024
Back to search
Official data from USPTO
RHEUMATE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
01/14/2025
Trademark type
Word
Nice classes
5
Filing date
10/22/2013
Registration date
08/18/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/25/2024
Last transaction
01/14/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/05/2014
First use in commerce
03/05/2014
Drawing code
4
Owner type
03
Owner location
Scottsdale, AZ
Examiner
KUYKENDALL, LYNDSEY
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Primus Pharmaceuticals, Inc.
Representatives
Eric Lamb FROST BROWN TODD LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medical foods supplement in form of capsules for the clinical dietary management of patients with chronic inflammatory diseases; pharmaceutical preparations for patients with chronic inflammatory diseases
Publications
History of USPTO decisions and trademark events.
41 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
12/25/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/25/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/25/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
09/13/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/18/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/07/2020
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/07/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/07/2020
E815
TEAS SECTION 8 & 15 RECEIVED
08/24/2020
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/18/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
08/18/2015
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/17/2015
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/16/2015
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/14/2015
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/14/2015
IUAF
USE AMENDMENT FILED
06/16/2015
EISU
TEAS STATEMENT OF USE RECEIVED
06/16/2015
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/26/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/31/2015
PUBO
PUBLISHED FOR OPPOSITION
03/31/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/11/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/20/2015
ALIE
ASSIGNED TO LIE
02/20/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/31/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
01/31/2015
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/31/2015
GNEA
EXAMINERS AMENDMENT E-MAILED
01/31/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/31/2015
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
08/08/2014
GNFR
FINAL REFUSAL E-MAILED
08/08/2014
CNFR
FINAL REFUSAL WRITTEN
08/08/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/06/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/06/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/06/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/06/2014
GNRT
NON-FINAL ACTION E-MAILED
02/06/2014
CNRT
NON-FINAL ACTION WRITTEN
02/06/2014
DOCK
ASSIGNED TO EXAMINER
02/05/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/28/2013
NWAP
NEW APPLICATION ENTERED
10/25/2013
Continuous trademark protection
Get notified about every new filing that threatens RHEUMATE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.